Calcium channel antagonists: clinical uses--past, present and future.
about
Calcium antagonists as an add-on therapy for drug-resistant epilepsyCalcium channel blockers versus other classes of drugs for hypertensionMMP-2 induced vein relaxation via inhibition of [Ca2+]e-dependent mechanisms of venous smooth muscle contraction. Role of RGD peptidesThe Concise Guide to PHARMACOLOGY 2013/14: ion channelsCocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addictionMolecular mechanisms, and selective pharmacological rescue, of Rem-inhibited CaV1.2 channels in heart.Distinct RGK GTPases differentially use α1- and auxiliary β-binding-dependent mechanisms to inhibit CaV1.2/CaV2.2 channels.Bio-inspired voltage-dependent calcium channel blockersCa(V)1.2 channel N-terminal splice variants modulate functional surface expression in resistance size artery smooth muscle cellsAnti-neuroinflammatory effects of the calcium channel blocker nicardipine on microglial cells: implications for neuroprotection.Ca(2+)-dependent contraction by the saponoside escin in rat vena cava: implications in venotonic treatment of varicose veins.Unique properties of muscularis mucosae smooth muscle in guinea pig urinary bladder.One-pot pseudo three-component reaction of nitroketene-N,S-acetals and aldehydes for synthesis of highly functionalized hexa-substituted 1,4-dihydropyridines.Meta-Analysis of Public Microarray Datasets Reveals Voltage-Gated Calcium Gene Signatures in Clinical Cancer Patients.Calcium channels of schistosomes: unresolved questions and unexpected answersPhenotypic screens as a renewed approach for drug discovery.Synthesis and study of new paramagnetic and diamagnetic verapamil derivatives.Identification of Novel Human Breast Carcinoma (MDA-MB-231) Cell Growth Modulators from a Carbohydrate-Based Diversity Oriented Synthesis Library.Cardioprotective effects of fatty acid amide hydrolase inhibitor URB694, in a rodent model of trait anxiety.AT1-receptor response to non-saturating Ang-II concentrations is amplified by calcium channel blockersDihydropyridine Ca(2+) channel blockers increase cytosolic [Ca(2+)] by activating Ca(2+)-sensing receptors in pulmonary arterial smooth muscle cellsAging Reduces L-Type Calcium Channel Current and the Vasodilatory Response of Small Mesenteric Arteries to Calcium Channel BlockersSimilar molecular determinants on Rem mediate two distinct modes of inhibition of CaV1.2 channels.Alternative splicing of Cav1.2 channel exons in smooth muscle cells of resistance-size arteries generates currents with unique electrophysiological properties.Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes.Effects of wenxin keli on the action potential and L-type calcium current in rats with transverse aortic constriction-induced heart failure.Engineering proteins for custom inhibition of Ca(V) channels.Cooperative and acute inhibition by multiple C-terminal motifs of L-type Ca2+ channels.Antischistosomal activity of a calcium channel antagonist on schistosomula and adult Schistosoma mansoni wormsTargeting voltage-gated calcium channels: developments in peptide and small-molecule inhibitors for the treatment of neuropathic pain.Regulation of voltage-dependent calcium channels by RGK proteins.Calcium channel blockers in cardiovascular pharmacotherapy.Recent patents on calcium channel blockers: emphasis on CNS diseases.Calcium Homeostasis and Ionic Mechanisms in Pulmonary Fibroblasts.Propargylamine as functional moiety in the design of multifunctional drugs for neurodegenerative disorders: MAO inhibition and beyond.Voltage gated sodium channels as drug discovery targetsDrug use among men with unfulfilled wish to father children: a retrospective analysis and discussion of specific drug classes.Investigational calcium channel blockers for the treatment of hypertension.Azilsartan Medoxomil, an Angiotensin II Receptor Antagonist for the Treatment of Hypertension.Interaction of diltiazem with an intracellularly accessible binding site on Ca(V)1.2.
P2860
Q24198886-4C936699-C02A-4898-962C-5763E6C329E3Q24236584-CC2AE68A-2088-411B-BBB1-C42578B35A7AQ28584210-4F11E0C4-9CAA-443C-BEEB-C8CECB8E2CF6Q30486735-D8619122-8F5C-46C5-8C2C-DA5158117F14Q33626978-43648806-D42A-4D95-B962-FE164CADE1C8Q34187371-126DF2CC-A990-4875-AB0A-0E3BA26F97F8Q34271168-A7BFD839-7A71-4927-82DE-C6A94E25C0D9Q34308192-2763500D-9CCF-4B4B-9BFF-53A27DE93B51Q34868795-BE330FA7-7C6C-4AC0-970E-E2D95E19CB4EQ35118654-3E6CA939-B904-4BCF-B1DC-F80572431B52Q35118809-44458E19-088B-4378-8AD0-23DC6EEC2BBEQ35160050-F675CE71-90C3-4F62-8367-DC93413B3A83Q35204016-AE644E8A-D961-4F3F-A690-D6FA9739DDDDQ35683329-3B677A78-6A95-4034-9155-DB54BB799A22Q35752884-D1CA212A-CD06-46D4-8D88-68C973D488D5Q35936197-DCB280FF-576F-4742-A5F1-C1FD224F38C4Q36131685-CD205CB1-B877-4B56-8FD1-D5A5DD6BA8CEQ36172912-85615E9D-2A0D-487B-BC39-48EAD232F5F3Q36367355-122C4FBA-A2D8-4683-A94E-429673BED7E7Q36374225-E21D6ACA-E42A-42CC-911F-499893470ACAQ36811753-B5F4FAB3-80FE-4C21-93C2-350A726115B1Q36918354-4D0D98CA-D9B9-48AA-BEE4-A8385C0E27C0Q37183263-DF0956CD-D9EA-4FC3-B37B-13A1813FBFB2Q37298267-CD618F40-F672-490C-B889-C0E490EC0343Q37312565-3624B4AC-A3C3-4A0B-BE85-533B1FC19C0CQ37351561-44D340C2-6530-4F88-8822-02FBEF91744CQ37578943-EF19BE99-2FC6-43E0-A8F8-FB2896328204Q37613903-8093BB2B-298C-4BC4-B2A7-C27B2C37E25FQ37674908-212EAD96-E421-4233-8481-226319969FA0Q38020929-016B53D2-CD27-4FF8-923F-055581C5C555Q38051949-5B895C97-D282-4B04-A56D-5FDB9FF46E54Q38215726-1D5E5989-794C-495A-9E08-B6A3E47C464BQ38239508-9F78E78C-DCF5-4AA9-80D8-F1AB2A8D67E5Q38382787-F5043994-6A24-4FEA-B777-B0BE2A2FECE5Q38447289-DC35C684-BDAA-47A7-B6EB-385291FEEDE5Q38662546-49ECF350-35BF-4A2D-83FF-328EE704A6B7Q38757168-C587E3B9-B4E9-4964-AA80-FC3D87E54046Q38970773-40882B2B-7BA5-427E-8198-9E260E2D4949Q39264079-66EA9E05-099D-495F-81C2-47CBDDEEEE81Q39640258-F4E982A7-A952-46CC-9954-12B229EBD854
P2860
Calcium channel antagonists: clinical uses--past, present and future.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Calcium channel antagonists: clinical uses--past, present and future.
@ast
Calcium channel antagonists: clinical uses--past, present and future.
@en
type
label
Calcium channel antagonists: clinical uses--past, present and future.
@ast
Calcium channel antagonists: clinical uses--past, present and future.
@en
prefLabel
Calcium channel antagonists: clinical uses--past, present and future.
@ast
Calcium channel antagonists: clinical uses--past, present and future.
@en
P1476
Calcium channel antagonists: clinical uses--past, present and future.
@en
P2093
David J Triggle
P356
10.1016/J.BCP.2007.01.016
P407
P577
2007-01-13T00:00:00Z